Versant Capital Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$2.89K Buy
105
+10
+11% +$301 ﹤0.01% 2555
2026
Q2
$2.8K Buy
95
+12
+14% +$308 ﹤0.01% 2519
2026
Q1
$1.94K Buy
83
+69
+493% +$1.25K ﹤0.01% 2574
2025
Q4
$199 Sell
14
-183
-93% -$3.46K ﹤0.01% 2620
2025
Q3
$4.88K Sell
197
-1
-0.5% -$22 ﹤0.01% 2215
2025
Q2
$4.49K Buy
+198
New +$4.69K ﹤0.01% 2195
2023
Q2
– Sell
-23
Closed -$1.66K – 2044
2023
Q1
$1.66K Buy
+23
New +$1.79K ﹤0.01% 1319
2020
Q1
– Sell
-14
Closed – – 1271
2019
Q4
$0 Hold
14
– – ﹤0.01% 1329
2019
Q3
$0 Sell
14
-7
-33% -$213 ﹤0.01% 1345
2019
Q2
$0 Hold
21
– – ﹤0.01% 1369
2019
Q1
$0 Buy
+21
New +$595 ﹤0.01% 1536

Other funds holding ACHC

Versant Capital Management's ACHC Position: Q3 2026 in Review

Versant Capital Management increased its Acadia Healthcare (ACHC) stake by 11% in Q3 2026, buying an estimated $301 and bringing the position to 105 shares worth $2.89K. The position accounts for ﹤0.01% of the portfolio, ranked #2555.

Versant Capital Management first reported a position in ACHC in Q1 2019 and has held it in 11 quarters since. The position peaked at $4.88K in Q3 2025. 291 funds tracked by Wall St. Rank hold ACHC as of Q3 2026.

  • Versant Capital Management held 105 shares of Acadia Healthcare worth $2.89K as of Q3 2026.
  • Versant Capital Management bought 10 Acadia Healthcare shares in Q3 2026, an estimated $301.
  • Acadia Healthcare made up ﹤0.01% of Versant Capital Management's portfolio in Q3 2026, its #2555 holding.
  • Versant Capital Management first reported a position in Acadia Healthcare in Q1 2019 and has held it in 11 quarters since.
  • Versant Capital Management's Acadia Healthcare position peaked at $4.88K in Q3 2025.
  • 291 funds tracked by Wall St. Rank held Acadia Healthcare as of Q3 2026.

Based on Versant Capital Management's 13F filing for Q3 2026, filed 2 Oct 2026.